Furthermore, an analysis of five GC cell lines and 135 GC primary tumor samples revealed that patients with GAS41 overexpressing tumors have lower overall survival rates, and cell lines with GAS41 knockouts exhibit significantly increased chemosensitivity to CDDP (Cisplatin) and L-OHP [44]. This evidence concerns the gene YEATS4 and gastric cancer.